Skip to main navigation Skip to search Skip to main content

Synthesis and identification of novel indolo[2,3-a]pyrimido[5,4-c] carbazoles as a new class of anti-cancer agents

Research output: Contribution to journalArticlepeer-review

Abstract

A range of 5,6-bisindole and 5-indole-6-(7-azaindole)pyrimidinones were synthesised via a β-keto ester intermediate and a screen of cyclisation conditions undertaken. The optimised route to this new class of indolocarbazoles and azaindolocarbazoles involved photocyclisation, with typical yields of 50-60%. These derivatives were screened for anti-cancer activity via topo II inhibition and the NCI-60 cell line assay, with the screening indicating a lack of topo II inhibition, but significant in vitro growth inhibition within this new chemical class, in the low micromolar range against renal cancer, melanoma and colon cancer cell lines.

Original languageEnglish
Pages (from-to)292-300
Number of pages9
JournalEuropean Journal of Medicinal Chemistry
Volume56
DOIs
Publication statusPublished - Oct 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Anti-cancer
  • Azaindolocarbazoles
  • Bisindolylmaleimides
  • Indolocarbazoles
  • Photocyclisation
  • Pyrimidines
  • Topoisomerase II

Fingerprint

Dive into the research topics of 'Synthesis and identification of novel indolo[2,3-a]pyrimido[5,4-c] carbazoles as a new class of anti-cancer agents'. Together they form a unique fingerprint.

Cite this